Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

Lung Cancer ◽  
2003 ◽  
Vol 41 (1) ◽  
pp. 107-111 ◽  
Author(s):  
Dimosthenis-Vasilios Skarlos ◽  
Athanassios-Meletios Dimopoulos ◽  
Paraskevas Kosmidis ◽  
Pavlos Papakostas ◽  
Nicholas Pavlidis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Oncology Group ◽  
Small Cell Lung ◽  
First Line ◽  
Extensive Disease ◽  
First Line Treatment

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

1997 ◽  
Vol 33 ◽  
pp. S236 ◽  
Author(s):  
N. Androulakis ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
A.M. Dimopoulos ◽  
E. Papadakis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7073-7073 ◽  
Author(s):  
G. Giaccone ◽  
T. Lechevalier ◽  
N. Thatcher ◽  
E. Smit ◽  
M. Janmaat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document